VThunter
a database for single-cell screening of virus target cells in animal kingdom
Goat

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; Caprinae; Capra,

Latin Name: Capra aegagrus hircus

Tested tissues: Lung, PBMC,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_0047 2021.04 10X Genomics Lung Normal 4681 Link
Vthunter_100007 2021.05 10X Genomics PBMC Normal 1043 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Middle East respiratory syndrome-related coronavirus
Lung-Mesothelial cells : 100.00% ;
Lung-Ciliated cells : 68.59% ;
Lung-Endothelial cells : 48.44% ;
Severe acute respiratory syndrome coronavirus 2
Lung-ATI : 94.50% ;
Lung-Fibroblasts : 87.08% ;
Lung-Smooth muscle cells : 85.78% ;
Lung-Ciliated cells : 81.53% ;
Lung-Secretory cells : 79.79% ;
Lung-Ciliated cells : 57.31% ;
Lung-Endothelial cells : 39.64% ;
Lung-Secretory cells : 36.27% ;
Lung-Macrophages : 27.77% ;
Lung-Ciliated cells : 39.57% ;
Lung-Dendritic cells : 37.50% ;
Lung-Macrophages : 25.32% ;
Lung-Smooth muscle cells : 24.83% ;
Rhinovirus C
Lung-Ciliated cells : 93.05% ;
Hepacivirus C
Lung-ATII : 91.15% ;
Lung-Ciliated cells : 90.89% ;
Lung-Secretory cells : 86.01% ;
Lung-Mesothelial cells : 84.62% ;
Lung-ATI : 83.70% ;
Lung-Ciliated cells : 60.91% ;
Lung-Dendritic cells : 50.00% ;
Lung-Mesothelial cells : 38.46% ;
Lung-T cells : 32.79% ;
Lung-Secretory cells : 30.05% ;
Lung-Ciliated cells : 60.67% ;
Lung-ATI : 34.48% ;
Lung-Macrophages : 32.66% ;
Lung-Secretory cells : 32.64% ;
Lung-Dendritic cells : 25.00% ;
Lung-Ciliated cells : 58.51% ;
Lung-ATI : 33.13% ;
Lung-Secretory cells : 23.32% ;
Lung-Ciliated cells : 57.31% ;
Lung-Endothelial cells : 39.64% ;
Lung-Secretory cells : 36.27% ;
Lung-Macrophages : 27.77% ;
Lung-Ciliated cells : 50.60% ;
Lung-ATII : 38.53% ;
Lung-Macrophages : 24.75% ;
Lung-Secretory cells : 23.32% ;
Influenza A virus
Lung-ATII : 91.15% ;
Lung-Ciliated cells : 90.89% ;
Lung-Secretory cells : 86.01% ;
Lung-Mesothelial cells : 84.62% ;
Lung-ATI : 83.70% ;
Lung-Ciliated cells : 90.41% ;
Lung-ATI : 89.62% ;
Lung-Dendritic cells : 87.50% ;
Lung-Secretory cells : 83.94% ;
Lung-Natural killer cells : 81.82% ;
Lung-Ciliated cells : 77.70% ;
Lung-Mesothelial cells : 53.85% ;
Lung-ATI : 48.81% ;
Lung-Fibroblasts : 37.64% ;
Lung-Macrophages : 31.22% ;
Lung-Ciliated cells : 31.89% ;
Lung-Fibroblasts : 29.78% ;
Human betaherpesvirus 5
Lung-ATII : 91.15% ;
Lung-Ciliated cells : 90.89% ;
Lung-Secretory cells : 86.01% ;
Lung-Mesothelial cells : 84.62% ;
Lung-ATI : 83.70% ;
Lung-Ciliated cells : 81.30% ;
Lung-ATI : 64.69% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 60.67% ;
Lung-Secretory cells : 54.40% ;
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Lung-Ciliated cells : 62.59% ;
Lung-ATII : 51.51% ;
Lung-Mesothelial cells : 38.46% ;
Lung-Secretory cells : 37.82% ;
Lung-Fibroblasts : 32.58% ;
Vesicular stomatitis virus
Lung-Ciliated cells : 90.41% ;
Lung-ATI : 89.62% ;
Lung-Dendritic cells : 87.50% ;
Lung-Secretory cells : 83.94% ;
Lung-Natural killer cells : 81.82% ;
Lung-Ciliated cells : 50.60% ;
Lung-ATII : 38.53% ;
Lung-Macrophages : 24.75% ;
Lung-Secretory cells : 23.32% ;
Feline leukemia virus strain B/lambda-B1
Lung-Ciliated cells : 86.57% ;
Lung-ATI : 50.16% ;
Lung-Secretory cells : 47.15% ;
Lung-Mesothelial cells : 46.15% ;
Lung-Fibroblasts : 40.45% ;
Lung-Ciliated cells : 60.19% ;
Lung-Mesothelial cells : 38.46% ;
Lung-Natural killer cells : 36.36% ;
PBMC-NKs : 35.71% ;
PBMC-B cells : 33.52% ;
Amphotropic murine leukemia virus
Lung-Ciliated cells : 86.57% ;
Lung-ATI : 50.16% ;
Lung-Secretory cells : 47.15% ;
Lung-Mesothelial cells : 46.15% ;
Lung-Fibroblasts : 40.45% ;
Gibbon ape leukemia virus
Lung-Ciliated cells : 86.57% ;
Lung-ATI : 50.16% ;
Lung-Secretory cells : 47.15% ;
Lung-Mesothelial cells : 46.15% ;
Lung-Fibroblasts : 40.45% ;
Lung-Ciliated cells : 60.19% ;
Lung-Mesothelial cells : 38.46% ;
Lung-Natural killer cells : 36.36% ;
PBMC-NKs : 35.71% ;
PBMC-B cells : 33.52% ;
Foot-and-mouth disease virus
Lung-Ciliated cells : 85.61% ;
Lung-Mesothelial cells : 84.62% ;
Lung-Secretory cells : 79.27% ;
Lung-ATI : 67.91% ;
Lung-ATII : 60.56% ;
Lung-Ciliated cells : 81.30% ;
Lung-ATI : 64.69% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 60.67% ;
Lung-Secretory cells : 54.40% ;
Lung-Ciliated cells : 72.18% ;
Lung-Secretory cells : 62.69% ;
Lung-ATI : 49.53% ;
Lung-ATII : 45.17% ;
Lung-Dendritic cells : 25.00% ;
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Lung-Ciliated cells : 23.26% ;
Human alphaherpesvirus 1
Lung-Ciliated cells : 85.61% ;
Lung-Mesothelial cells : 84.62% ;
Lung-Secretory cells : 79.27% ;
Lung-ATI : 67.91% ;
Lung-ATII : 60.56% ;
Lung-Ciliated cells : 81.30% ;
Lung-ATI : 64.69% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 60.67% ;
Lung-Secretory cells : 54.40% ;
Lung-Ciliated cells : 72.18% ;
Lung-Secretory cells : 62.69% ;
Lung-ATI : 49.53% ;
Lung-ATII : 45.17% ;
Lung-Dendritic cells : 25.00% ;
Lung-Ciliated cells : 51.80% ;
Lung-ATII : 27.67% ;
Lung-ATI : 25.65% ;
Lung-Secretory cells : 24.87% ;
Lung-Ciliated cells : 40.77% ;
Lung-Mesothelial cells : 23.08% ;
Adeno-associated virus - 2
Lung-Ciliated cells : 84.41% ;
Lung-ATI : 84.01% ;
Lung-Secretory cells : 65.80% ;
Lung-ATII : 55.33% ;
Lung-Dendritic cells : 50.00% ;
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Lung-Ciliated cells : 49.16% ;
PBMC-DCs : 38.46% ;
Lung-B cells : 29.41% ;
Lung-Natural killer cells : 27.27% ;
Lung-Secretory cells : 26.42% ;
Lung-Ciliated cells : 23.26% ;
Human parechovirus 1
Lung-Ciliated cells : 81.30% ;
Lung-ATI : 64.69% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 60.67% ;
Lung-Secretory cells : 54.40% ;
West Nile virus
Lung-Ciliated cells : 81.30% ;
Lung-ATI : 64.69% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 60.67% ;
Lung-Secretory cells : 54.40% ;
Coxsackievirus A9
Lung-Ciliated cells : 81.30% ;
Lung-ATI : 64.69% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 60.67% ;
Lung-Secretory cells : 54.40% ;
Lung-Ciliated cells : 72.18% ;
Lung-Secretory cells : 62.69% ;
Lung-ATI : 49.53% ;
Lung-ATII : 45.17% ;
Lung-Dendritic cells : 25.00% ;
Human gammaherpesvirus 8
Lung-Ciliated cells : 81.30% ;
Lung-ATI : 64.69% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 60.67% ;
Lung-Secretory cells : 54.40% ;
Coxsackievirus B1
Lung-Ciliated cells : 81.30% ;
Lung-ATI : 64.69% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 60.67% ;
Lung-Secretory cells : 54.40% ;
Lung-Ciliated cells : 72.18% ;
Lung-Secretory cells : 62.69% ;
Lung-ATI : 49.53% ;
Lung-ATII : 45.17% ;
Lung-Dendritic cells : 25.00% ;
Lung-Ciliated cells : 53.24% ;
Lung-Mesothelial cells : 30.77% ;
Lung-ATI : 27.62% ;
Lung-Secretory cells : 23.83% ;
Simian rotavirus A strain RRV
Lung-Ciliated cells : 81.30% ;
Lung-ATI : 64.69% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 60.67% ;
Lung-Secretory cells : 54.40% ;
Lung-Ciliated cells : 68.35% ;
PBMC-B cells : 52.38% ;
Lung-Mesothelial cells : 46.15% ;
Lung-ATI : 41.43% ;
Lung-Fibroblasts : 41.01% ;
Lung-Ciliated cells : 67.15% ;
Lung-ATI : 58.05% ;
Lung-Secretory cells : 33.16% ;
Lung-Endothelial cells : 33.08% ;
Lung-Fibroblasts : 32.02% ;
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Lung-Ciliated cells : 61.39% ;
Lung-Endothelial cells : 59.76% ;
Human mastadenovirus C
Lung-Ciliated cells : 81.30% ;
Lung-ATI : 64.69% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 60.67% ;
Lung-Secretory cells : 54.40% ;
Lung-Ciliated cells : 54.92% ;
Lung-Mesothelial cells : 38.46% ;
Lung-Smooth muscle cells : 36.34% ;
Lung-Macrophages : 29.93% ;
Lung-Fibroblasts : 25.84% ;
Lung-Ciliated cells : 53.24% ;
Lung-Mesothelial cells : 30.77% ;
Lung-ATI : 27.62% ;
Lung-Secretory cells : 23.83% ;
Xenotropic murine leukemia virus
Lung-Ciliated cells : 79.38% ;
Lung-B cells : 50.00% ;
Lung-Endothelial cells : 47.39% ;
Lung-Macrophages : 45.18% ;
Lung-Fibroblasts : 42.70% ;
Polytropic murine leukemia virus
Lung-Ciliated cells : 79.38% ;
Lung-B cells : 50.00% ;
Lung-Endothelial cells : 47.39% ;
Lung-Macrophages : 45.18% ;
Lung-Fibroblasts : 42.70% ;
Human alphaherpesvirus 3
Lung-Dendritic cells : 75.00% ;
Lung-Ciliated cells : 71.22% ;
Lung-ATI : 50.05% ;
Lung-Secretory cells : 49.74% ;
Lung-Fibroblasts : 40.45% ;
Varicella Zoster Virus
Lung-Dendritic cells : 75.00% ;
Lung-Ciliated cells : 71.22% ;
Lung-ATI : 50.05% ;
Lung-Secretory cells : 49.74% ;
Lung-Fibroblasts : 40.45% ;
Human mastadenovirus B
Lung-Dendritic cells : 75.00% ;
Lung-Ciliated cells : 35.01% ;
Lung-Ciliated cells : 47.24% ;
Lung-Macrophages : 39.14% ;
Lung-Natural killer cells : 27.27% ;
Lung-Dendritic cells : 25.00% ;
Japanese encephalitis virus
Lung-Ciliated cells : 73.14% ;
Lung-Mesothelial cells : 53.85% ;
Lung-Natural killer cells : 45.45% ;
Lung-Macrophages : 41.01% ;
Lung-Endothelial cells : 37.85% ;
Lung-Ciliated cells : 41.01% ;
Coxsackievirus A10
Lung-Ciliated cells : 69.30% ;
Lung-ATI : 59.29% ;
Lung-Secretory cells : 34.20% ;
Lung-Fibroblasts : 31.46% ;
Lung-Smooth muscle cells : 25.96% ;
Feline calicivirus
Lung-Ciliated cells : 67.15% ;
Lung-ATI : 58.05% ;
Lung-Secretory cells : 33.16% ;
Lung-Endothelial cells : 33.08% ;
Lung-Fibroblasts : 32.02% ;
Human rotavirus strain WA
Lung-Ciliated cells : 67.15% ;
Lung-ATI : 58.05% ;
Lung-Secretory cells : 33.16% ;
Lung-Endothelial cells : 33.08% ;
Lung-Fibroblasts : 32.02% ;
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Lung-Ciliated cells : 61.39% ;
Lung-Endothelial cells : 59.76% ;
Mammalian orthoreovirus
Lung-Ciliated cells : 67.15% ;
Lung-ATI : 58.05% ;
Lung-Secretory cells : 33.16% ;
Lung-Endothelial cells : 33.08% ;
Lung-Fibroblasts : 32.02% ;
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Hendra henipavirus
Lung-Ciliated cells : 66.91% ;
Lung-Endothelial cells : 65.87% ;
Lung-Fibroblasts : 33.71% ;
Lung-B cells : 32.35% ;
Lung-Macrophages : 30.79% ;
Nipah henipavirus
Lung-Ciliated cells : 66.91% ;
Lung-Endothelial cells : 65.87% ;
Lung-Fibroblasts : 33.71% ;
Lung-B cells : 32.35% ;
Lung-Macrophages : 30.79% ;
Ebola virus
Lung-Ciliated cells : 66.19% ;
Lung-Macrophages : 63.74% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 50.56% ;
Lung-Endothelial cells : 35.62% ;
Lung-Ciliated cells : 41.01% ;
Lung-Ciliated cells : 39.57% ;
Lung-Dendritic cells : 37.50% ;
Lung-Macrophages : 25.32% ;
Lung-Smooth muscle cells : 24.83% ;
Marburg marburgvirus
Lung-Ciliated cells : 66.19% ;
Lung-Macrophages : 63.74% ;
Lung-Dendritic cells : 62.50% ;
Lung-Fibroblasts : 50.56% ;
Lung-Endothelial cells : 35.62% ;
Lung-Ciliated cells : 39.57% ;
Lung-Dendritic cells : 37.50% ;
Lung-Macrophages : 25.32% ;
Lung-Smooth muscle cells : 24.83% ;
Echovirus E1
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Lung-Ciliated cells : 61.39% ;
Lung-Endothelial cells : 59.76% ;
Human parvovirus B19
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Lung-Ciliated cells : 23.26% ;
Human gammaherpesvirus 4
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Equid alphaherpesvirus 1
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Lung-T cells : 63.93% ;
Lung-Ciliated cells : 60.43% ;
Lung-B cells : 41.18% ;
Lung-Natural killer cells : 36.36% ;
PBMC-T cells : 34.17% ;
Human metapneumovirus
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Lung-Ciliated cells : 23.26% ;
Echovirus E8
Lung-Ciliated cells : 65.95% ;
Lung-ATI : 46.31% ;
Lung-Fibroblasts : 39.33% ;
PBMC-T cells : 39.22% ;
Lung-Secretory cells : 38.34% ;
Lung-Ciliated cells : 61.39% ;
Lung-Endothelial cells : 59.76% ;
Transmissible gastroenteritis virus
Lung-Ciliated cells : 62.59% ;
Lung-ATII : 51.51% ;
Lung-Mesothelial cells : 38.46% ;
Lung-Secretory cells : 37.82% ;
Lung-Fibroblasts : 32.58% ;
Canine coronavirus
Lung-Ciliated cells : 62.59% ;
Lung-ATII : 51.51% ;
Lung-Mesothelial cells : 38.46% ;
Lung-Secretory cells : 37.82% ;
Lung-Fibroblasts : 32.58% ;
Feline coronavirus
Lung-Ciliated cells : 62.59% ;
Lung-ATII : 51.51% ;
Lung-Mesothelial cells : 38.46% ;
Lung-Secretory cells : 37.82% ;
Lung-Fibroblasts : 32.58% ;
Porcine epidemic diarrhea virus
Lung-Ciliated cells : 62.59% ;
Lung-ATII : 51.51% ;
Lung-Mesothelial cells : 38.46% ;
Lung-Secretory cells : 37.82% ;
Lung-Fibroblasts : 32.58% ;
Infectious bronchitis virus
Lung-Ciliated cells : 62.59% ;
Lung-ATII : 51.51% ;
Lung-Mesothelial cells : 38.46% ;
Lung-Secretory cells : 37.82% ;
Lung-Fibroblasts : 32.58% ;
Human coronavirus 229E
Lung-Ciliated cells : 62.59% ;
Lung-ATII : 51.51% ;
Lung-Mesothelial cells : 38.46% ;
Lung-Secretory cells : 37.82% ;
Lung-Fibroblasts : 32.58% ;
Oliveros mammarenavirus
Lung-Ciliated cells : 61.63% ;
Lung-ATI : 30.32% ;
Lung-Fibroblasts : 24.16% ;
Lung-Mesothelial cells : 23.08% ;
Latino mammarenavirus
Lung-Ciliated cells : 61.63% ;
Lung-ATI : 30.32% ;
Lung-Fibroblasts : 24.16% ;
Lung-Mesothelial cells : 23.08% ;
Lassa mammarenavirus
Lung-Ciliated cells : 61.63% ;
Lung-ATI : 30.32% ;
Lung-Fibroblasts : 24.16% ;
Lung-Mesothelial cells : 23.08% ;
Lung-Dendritic cells : 50.00% ;
Lung-Ciliated cells : 44.12% ;
Lung-Ciliated cells : 41.01% ;
Lung-Ciliated cells : 39.57% ;
Lung-Dendritic cells : 37.50% ;
Lung-Macrophages : 25.32% ;
Lung-Smooth muscle cells : 24.83% ;
Lymphocytic choriomeningitis mammarenavirus
Lung-Ciliated cells : 61.63% ;
Lung-ATI : 30.32% ;
Lung-Fibroblasts : 24.16% ;
Lung-Mesothelial cells : 23.08% ;
Lung-Ciliated cells : 41.01% ;
Lung-Ciliated cells : 39.57% ;
Lung-Dendritic cells : 37.50% ;
Lung-Macrophages : 25.32% ;
Lung-Smooth muscle cells : 24.83% ;
Guanarito mammarenavirus
Lung-Ciliated cells : 60.91% ;
Lung-Dendritic cells : 50.00% ;
Lung-Mesothelial cells : 38.46% ;
Lung-T cells : 32.79% ;
Lung-Secretory cells : 30.05% ;
Canine parvovirus
Lung-Ciliated cells : 60.91% ;
Lung-Dendritic cells : 50.00% ;
Lung-Mesothelial cells : 38.46% ;
Lung-T cells : 32.79% ;
Lung-Secretory cells : 30.05% ;
Feline panleukopenia virus
Lung-Ciliated cells : 60.91% ;
Lung-Dendritic cells : 50.00% ;
Lung-Mesothelial cells : 38.46% ;
Lung-T cells : 32.79% ;
Lung-Secretory cells : 30.05% ;
Argentinian mammarenavirus
Lung-Ciliated cells : 60.91% ;
Lung-Dendritic cells : 50.00% ;
Lung-Mesothelial cells : 38.46% ;
Lung-T cells : 32.79% ;
Lung-Secretory cells : 30.05% ;
Machupo mammarenavirus
Lung-Ciliated cells : 60.91% ;
Lung-Dendritic cells : 50.00% ;
Lung-Mesothelial cells : 38.46% ;
Lung-T cells : 32.79% ;
Lung-Secretory cells : 30.05% ;
Mouse mammary tumor virus
Lung-Ciliated cells : 60.91% ;
Lung-Dendritic cells : 50.00% ;
Lung-Mesothelial cells : 38.46% ;
Lung-T cells : 32.79% ;
Lung-Secretory cells : 30.05% ;
Dengue virus
Lung-Ciliated cells : 60.67% ;
Lung-ATI : 34.48% ;
Lung-Macrophages : 32.66% ;
Lung-Secretory cells : 32.64% ;
Lung-Dendritic cells : 25.00% ;
Lung-Ciliated cells : 49.16% ;
PBMC-DCs : 38.46% ;
Lung-B cells : 29.41% ;
Lung-Natural killer cells : 27.27% ;
Lung-Secretory cells : 26.42% ;
Lung-Ciliated cells : 39.57% ;
Lung-Dendritic cells : 37.50% ;
Lung-Macrophages : 25.32% ;
Lung-Smooth muscle cells : 24.83% ;
Simian sarcoma-associated virus
Lung-Ciliated cells : 60.19% ;
Lung-Mesothelial cells : 38.46% ;
Lung-Natural killer cells : 36.36% ;
PBMC-NKs : 35.71% ;
PBMC-B cells : 33.52% ;
Hepatitis E virus
Lung-ATI : 54.31% ;
Lung-Ciliated cells : 49.40% ;
Lung-Fibroblasts : 26.40% ;
Human mastadenovirus E
Lung-Ciliated cells : 53.24% ;
Lung-Mesothelial cells : 30.77% ;
Lung-ATI : 27.62% ;
Lung-Secretory cells : 23.83% ;
Coxsackievirus B4
Lung-Ciliated cells : 53.24% ;
Lung-Mesothelial cells : 30.77% ;
Lung-ATI : 27.62% ;
Lung-Secretory cells : 23.83% ;
Coxsackievirus B6
Lung-Ciliated cells : 53.24% ;
Lung-Mesothelial cells : 30.77% ;
Lung-ATI : 27.62% ;
Lung-Secretory cells : 23.83% ;
Human mastadenovirus F
Lung-Ciliated cells : 53.24% ;
Lung-Mesothelial cells : 30.77% ;
Lung-ATI : 27.62% ;
Lung-Secretory cells : 23.83% ;
Coxsackievirus B5
Lung-Ciliated cells : 53.24% ;
Lung-Mesothelial cells : 30.77% ;
Lung-ATI : 27.62% ;
Lung-Secretory cells : 23.83% ;
Coxsackievirus B2
Lung-Ciliated cells : 53.24% ;
Lung-Mesothelial cells : 30.77% ;
Lung-ATI : 27.62% ;
Lung-Secretory cells : 23.83% ;
Human mastadenovirus D
Lung-Ciliated cells : 53.24% ;
Lung-Mesothelial cells : 30.77% ;
Lung-ATI : 27.62% ;
Lung-Secretory cells : 23.83% ;
Human mastadenovirus A
Lung-Ciliated cells : 53.24% ;
Lung-Mesothelial cells : 30.77% ;
Lung-ATI : 27.62% ;
Lung-Secretory cells : 23.83% ;
Coxsackievirus B3
Lung-Ciliated cells : 53.24% ;
Lung-Mesothelial cells : 30.77% ;
Lung-ATI : 27.62% ;
Lung-Secretory cells : 23.83% ;
Bovine leukemia virus
Lung-Ciliated cells : 53.00% ;
PBMC-DCs : 34.62% ;
Lung-Natural killer cells : 27.27% ;
Lung-Macrophages : 23.45% ;
Human papillomavirus type 16
Lung-Ciliated cells : 53.00% ;
Lung-Endothelial cells : 36.21% ;
Lung-Natural killer cells : 27.27% ;
Lung-Mesothelial cells : 23.08% ;
Suid alphaherpesvirus 1
Lung-Ciliated cells : 51.80% ;
Lung-ATII : 27.67% ;
Lung-ATI : 25.65% ;
Lung-Secretory cells : 24.87% ;
Lung-Ciliated cells : 40.77% ;
Lung-Mesothelial cells : 23.08% ;
Lung-Dendritic cells : 25.00% ;
Human alphaherpesvirus 2
Lung-Ciliated cells : 51.80% ;
Lung-ATII : 27.67% ;
Lung-ATI : 25.65% ;
Lung-Secretory cells : 24.87% ;
Lung-Ciliated cells : 40.77% ;
Lung-Mesothelial cells : 23.08% ;
Human rhinovirus A2
Lung-Ciliated cells : 50.60% ;
Lung-ATII : 38.53% ;
Lung-Macrophages : 24.75% ;
Lung-Secretory cells : 23.32% ;
Coxsackievirus A21
Lung-Dendritic cells : 50.00% ;
Lung-Ciliated cells : 35.49% ;
Rhinovirus B14
Lung-Dendritic cells : 50.00% ;
Lung-Ciliated cells : 35.49% ;
Classical swine fever virus
Lung-Ciliated cells : 49.16% ;
PBMC-DCs : 38.46% ;
Lung-B cells : 29.41% ;
Lung-Natural killer cells : 27.27% ;
Lung-Secretory cells : 26.42% ;
Adeno-associated virus - 3
Lung-Ciliated cells : 49.16% ;
PBMC-DCs : 38.46% ;
Lung-B cells : 29.41% ;
Lung-Natural killer cells : 27.27% ;
Lung-Secretory cells : 26.42% ;
Adeno-associated virus 9
Lung-Ciliated cells : 49.16% ;
PBMC-DCs : 38.46% ;
Lung-B cells : 29.41% ;
Lung-Natural killer cells : 27.27% ;
Lung-Secretory cells : 26.42% ;
Adeno-associated virus - 8
Lung-Ciliated cells : 49.16% ;
PBMC-DCs : 38.46% ;
Lung-B cells : 29.41% ;
Lung-Natural killer cells : 27.27% ;
Lung-Secretory cells : 26.42% ;
Sindbis virus
Lung-Ciliated cells : 49.16% ;
PBMC-DCs : 38.46% ;
Lung-B cells : 29.41% ;
Lung-Natural killer cells : 27.27% ;
Lung-Secretory cells : 26.42% ;
Venezuelan equine encephalitis virus
Lung-Ciliated cells : 49.16% ;
PBMC-DCs : 38.46% ;
Lung-B cells : 29.41% ;
Lung-Natural killer cells : 27.27% ;
Lung-Secretory cells : 26.42% ;
SARS coronavirus
Lung-Ciliated cells : 41.01% ;
Bovine alphaherpesvirus 1
Lung-Ciliated cells : 40.77% ;
Lung-Mesothelial cells : 23.08% ;
Lung-Dendritic cells : 25.00% ;
Zika virus
Lung-Ciliated cells : 39.57% ;
Lung-Dendritic cells : 37.50% ;
Lung-Macrophages : 25.32% ;
Lung-Smooth muscle cells : 24.83% ;
Feline leukemia virus strain C/FA27
Lung-Ciliated cells : 36.69% ;
Ecotropic murine leukemia virus
Lung-Ciliated cells : 36.45% ;
Lung-Mesothelial cells : 23.08% ;
Feline immunodeficiency virus
Lung-Ciliated cells : 31.89% ;
Lung-Dendritic cells : 25.00% ;
Human immunodeficiency virus 1
Lung-Ciliated cells : 31.89% ;
Lung-Dendritic cells : 25.00% ;
Human immunodeficiency virus 2
Lung-Ciliated cells : 31.89% ;
Lung-Dendritic cells : 25.00% ;
Enterovirus C
Lung-Dendritic cells : 25.00% ;
Simian type D retrovirus -Tsukuba
Lung-Ciliated cells : 24.46% ;
Feline endogenous virus RD114
Lung-Ciliated cells : 24.46% ;
Baboon endogenous virus strain M7
Lung-Ciliated cells : 24.46% ;
Rinderpest morbillivirus
Lung-Ciliated cells : 23.50% ;
Phocine morbillivirus
Lung-Ciliated cells : 23.50% ;
Canine morbillivirus
Lung-Ciliated cells : 23.50% ;
Measles morbillivirus
Lung-Ciliated cells : 23.50% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China